Skip to content
Screener

Reported August 13, 2026 · Before market open

EPS-$0.69Beat by $0.01
EPS estimate-$0.70

Next report

Date not yet announced

FAQ

When did Tvardi Therapeutics report Q2 2026 earnings?
Tvardi Therapeutics (TVRD) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Tvardi Therapeutics's Q2 2026 revenue and EPS?
Tvardi Therapeutics reported eps of $-0.69 for Q2 2026.
Did Tvardi Therapeutics beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.70 by $0.01.
How did Tvardi Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 31.0% from $-1.00.
Where can I find Tvardi Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-096417) and the 10-Q periodic report (0001104659-26-096424) directly on SEC EDGAR. The filing index links above go to sec.gov.